15 January 2026
A new special issue of Rheumatology brings together cutting-edge research on interstitial lung disease in connective tissue diseases (CTD-ILD), highlighting evolving strategies across the disease spectrum.
The issue covers the full range of CTD-ILD diagnosis and management - from early detection and disease monitoring to prognostication and therapeutic strategies.
Guest Editor Professor Rohit Aggarwal (University of Pittsburgh, PA, USA) and colleagues open the issue with a scene-setting review:
“With the publication of recent international guidelines, evidence-based management of CTD-ILD has become more structured, providing clinicians with a clearer framework for decision-making, while real-world studies continue to refine these approaches and identify remaining therapeutic gaps.”
This special issue showcases a summary of the latest insights and practical approaches that are shaping the future of CTD-ILD care. From innovative monitoring techniques to emerging treatment strategies, it’s an essential resource for anyone involved in managing these complex conditions.
Read the special issue below and keep an eye out for our first ILD guideline, coming later this year in Rheumatology.